Price target
3070.890.00 0.00%
The 18 analysts offering 1 year price forecasts for JAZZ/N have a max estimate of — and a min estimate of —.
Analyst rating
Based on 20 analysts giving stock ratings to JAZZ/N in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
JAZZ/N EPS for the last quarter is 44.41 MXN despite the estimation of 69.26 MXN. In the next quarter EPS is expected to reach 80.53 MXN. Track more of JAZZ PHARMACEUTICALS PLC financials and stay on top of what is up with the company.
In the next quarter JAZZ PHARMACEUTICALS PLC revenue is expected to reach 17.06 B MXN. Check out JAZZ PHARMACEUTICALS PLC revenue and earnings and make informed decisions.
According to analysts, JAZZ/N price target is 3070.89 MXN with a max estimate of 3906.91 MXN and a min estimate of 1987.43 MXN. Check if this forecast comes true in a year, meanwhile watch JAZZ PHARMACEUTICALS PLC stock price chart and keep track of the current situation with JAZZ/N news and stock market news.
We've gathered opinions of 20 analysts rating JAZZ/N stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.